The Spanish government has recently presented a draft bill proposing to put an end to the independent electronic cigarette industry in Spain and transfer the entire e-cigarette business to large tobacco companies.
The Spanish government is proposing to ban and shut down all e-cigarette shops across the country, as well as prohibit all online sales in its "Anteproyecto de Ley del Mercado de Tabacos y otros Productos Relacionados" (Draft Law on the Tobacco Market and Other Related Products). This move goes against all principles of EU law (such as equivalence, good regulation, good management, fair competition, and coordination) and would transfer the sales of e-cigarettes and e-cigarette liquids to the state monopoly of tobacco shops (estancos).
These measures clearly violate:
The EU's free competition and the free movement of goods within the internal market could result in severe unemployment during new economic crises. This could have a devastating impact on Spain's tobacco industry and limit personalized access to e-cigarette products, forcing consumers to purchase from tobacco shops that primarily sell combustible tobacco products.
IEVA is urging the Spanish government, medical institutions, autonomous communities and consulting agencies providing feedback on the draft legislation to carefully reconsider this measure and reject an unfair and disproportionate law that will only increase Spain's tobacco/smoking rate.
Click to view:
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
